Cargando…
Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
Given the difficulty of diagnosing early-stage pulmonary arterial hypertension (PAH) due to the lack of signs and symptoms, and the risk of an open lung biopsy, the precise pathological features of presymptomatic stage lung tissue remain unknown. It has been suggested that the maximum elevation of t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493808/ https://www.ncbi.nlm.nih.gov/pubmed/26150101 http://dx.doi.org/10.1186/s12931-015-0246-y |
_version_ | 1782379985546248192 |
---|---|
author | Sakao, Seiichiro Voelkel, Norbert F. Tanabe, Nobuhiro Tatsumi, Koichiro |
author_facet | Sakao, Seiichiro Voelkel, Norbert F. Tanabe, Nobuhiro Tatsumi, Koichiro |
author_sort | Sakao, Seiichiro |
collection | PubMed |
description | Given the difficulty of diagnosing early-stage pulmonary arterial hypertension (PAH) due to the lack of signs and symptoms, and the risk of an open lung biopsy, the precise pathological features of presymptomatic stage lung tissue remain unknown. It has been suggested that the maximum elevation of the mean pulmonary arterial pressure (P(pa)) is achieved during the early symptomatic stage, indicating that the elevation of the mean P(pa) is primarily driven by the pulmonary vascular tone and/or some degree of pulmonary vascular remodeling completed during this stage. Recently, the examination of a rat model of severe PAH suggested that the severe PAH may be primarily determined by the presence of intimal lesions and/or the vascular tone in the early stage. Human data seem to indicate that intimal lesions are essential for the severely increased pulmonary arterial blood pressure in the late stage of the disease. However, many questions remain. For instance, how does the pulmonary hemodynamics change during the course of the disease, and what drives the development of severe PAH? Although it is generally acknowledged that both pulmonary vascular remodeling and the vascular tone are important determinants of an elevated pulmonary arterial pressure, which is the root cause of the time-dependent progression of the disease? Here we review the recent histopathological concepts of PAH with respect to the progression of the lung vascular disease. |
format | Online Article Text |
id | pubmed-4493808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44938082015-07-08 Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension Sakao, Seiichiro Voelkel, Norbert F. Tanabe, Nobuhiro Tatsumi, Koichiro Respir Res Review Given the difficulty of diagnosing early-stage pulmonary arterial hypertension (PAH) due to the lack of signs and symptoms, and the risk of an open lung biopsy, the precise pathological features of presymptomatic stage lung tissue remain unknown. It has been suggested that the maximum elevation of the mean pulmonary arterial pressure (P(pa)) is achieved during the early symptomatic stage, indicating that the elevation of the mean P(pa) is primarily driven by the pulmonary vascular tone and/or some degree of pulmonary vascular remodeling completed during this stage. Recently, the examination of a rat model of severe PAH suggested that the severe PAH may be primarily determined by the presence of intimal lesions and/or the vascular tone in the early stage. Human data seem to indicate that intimal lesions are essential for the severely increased pulmonary arterial blood pressure in the late stage of the disease. However, many questions remain. For instance, how does the pulmonary hemodynamics change during the course of the disease, and what drives the development of severe PAH? Although it is generally acknowledged that both pulmonary vascular remodeling and the vascular tone are important determinants of an elevated pulmonary arterial pressure, which is the root cause of the time-dependent progression of the disease? Here we review the recent histopathological concepts of PAH with respect to the progression of the lung vascular disease. BioMed Central 2015-07-08 2015 /pmc/articles/PMC4493808/ /pubmed/26150101 http://dx.doi.org/10.1186/s12931-015-0246-y Text en © Sakao et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Sakao, Seiichiro Voelkel, Norbert F. Tanabe, Nobuhiro Tatsumi, Koichiro Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension |
title | Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension |
title_full | Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension |
title_fullStr | Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension |
title_full_unstemmed | Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension |
title_short | Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension |
title_sort | determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493808/ https://www.ncbi.nlm.nih.gov/pubmed/26150101 http://dx.doi.org/10.1186/s12931-015-0246-y |
work_keys_str_mv | AT sakaoseiichiro determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension AT voelkelnorbertf determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension AT tanabenobuhiro determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension AT tatsumikoichiro determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension |